Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activation
Open Access
- 29 August 2012
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 31 (1) , 73-80
Abstract
Activation of myeloid cells by orthopedic particulate debris is a key event in the pathogenesis of periprosthetic osteolysis and implant loosening after total joint replacement (TJR). Several lines of evidence implicate NACHT, LRR, and PYD domains‐containing protein 3 (NALP3) inflammasome‐mediated production of interleukin 1 beta (IL‐1β) in the pathogenesis of clinical disorders ascribable to foreign particulate materials, including asbestos, silica, and urate crystals. Recent reports indicate that orthopedic polymer products and metallic particulates and ions may activate the same pathway. Here, we investigated the contribution of the NALP3 inflammasome to the pathogenesis of peri‐implant osteolysis. Pharmaceutical and genetic perturbations of caspase‐1 and inflammasome components were used to assess the role of the NALP3 inflammasome in IL‐1β production and osteoclast formation by human monocytes and mouse macrophages in response to polymethylmethacrylate (PMMA) particle phagocytosis. The role of caspase‐1 in a mouse calvarial model of particle‐mediated osteolysis was assessed using µCT. Phagocytosis of PMMA particles induces caspase‐1 dependent release of IL‐1β from human monocytes and mouse macrophages. Importantly, using macrophages from mice deficient in components of the NALP3 inflammasome, we show PMMA‐induced IL‐1β production is strictly dependent on these components. Mice lacking caspase‐1, the sole effector of the NALP3 inflammasome, show reduced orthopedic wear particle‐induced calvarial osteolysis compared to wild‐type controls. Absence of NALP3 inflammasome components fails to alter osteoclast formation in vitro. Our findings identify the NALP3 inflammasome as a critical mediator of orthopedic wear‐induced osteolysis and as a viable therapeutic target for the treatment of periprosthetic osteolysis. © 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 31:73–80, 2012Keywords
This publication has 43 references indexed in Scilit:
- Temporal Interleukin-1β Secretion from Primary Human Peripheral Blood Monocytes by P2X7-independent and P2X7-dependent MechanismsJournal of Biological Chemistry, 2010
- Endosomal damage and TLR2 mediated inflammasome activation by alkane particles in the generation of aseptic osteolysisMolecular Immunology, 2009
- Innate instruction of adaptive immunity revisited: the inflammasomeEMBO Molecular Medicine, 2009
- Soluble and particulate Co‐Cr‐Mo alloy implant metals activate the inflammasome danger signaling pathway in human macrophages: A novel mechanism for implant debris reactivityJournal of Orthopaedic Research, 2008
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology, 2008
- The Nalp3 inflammasome is essential for the development of silicosisProceedings of the National Academy of Sciences, 2008
- Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvantsNature, 2008
- Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and SilicaScience, 2008
- Comparison of the response of primary human blood monocytes and the U937 human monocytic cell line to two different sizes of alumina ceramic particlesJournal of Orthopaedic Research, 2004
- Changes in macrophage morphology and prolonged cell viability following exposure to polyethylene particulate in vitroMicroscopy Research and Technique, 2002